Study of safety, tolerability, pharmacokinetics and pharmacodynamics of MSD-001 in healthy participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512939-67-00

Acronym

MSD001-NL-001

Enrollment

Registered

2024-05-22

Start date

2025-05-10

Completion date

2025-07-24

Last updated

2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental health disorders

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026